Distinguished in Temporal Arteritis

Simon Carette

Mount Sinai Hospital, 
CA 
Clinical Trials:Currently Recruiting for 2 Trials
Distinguished in Temporal Arteritis
Mount Sinai Hospital, 
CA 
OverviewLocationsClinical Research

Overview

Simon Carette practices in Canada. Mr. Carette is rated as a Distinguished expert by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Vasculitis, Granulomatosis with Polyangiitis, Takayasu Arteritis, and Giant Cell Arteritis (GCA).

His clinical research consists of co-authoring 74 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles and participated in 2 clinical trials in the study of Temporal Arteritis.

Gender
Male

Locations

Mount Sinai Hospital, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

VCRC Genetic Repository One-Time DNA Protocol
VCRC Genetic Repository One-Time DNA Protocol
Enrollment Status: Recruiting
Publish Date: June 12, 2025
Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis
Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis
Enrollment Status: Recruiting
Publish Date: May 21, 2025
The Assessment of Prednisone In Remission Trial (TAPIR) - Centers of Excellence Approach
The Assessment of Prednisone In Remission Trial (TAPIR) - Centers of Excellence Approach
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Drug
Study Drug: Prednisone
Study Phase: Phase 3
Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (ABROGATE)
Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (ABROGATE)
Enrollment Status: Completed
Publish Date: July 29, 2024
Intervention Type: Drug
Study Drug: Abatacept
Study Phase: Phase 3
Longitudinal Protocol of Polyarteritis Nodosa
Longitudinal Protocol of Polyarteritis Nodosa
Enrollment Status: Completed
Publish Date: July 12, 2022
Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Enrollment Status: Completed
Publish Date: July 12, 2022
Longitudinal Protocol for Giant Cell Arteritis
Longitudinal Protocol for Giant Cell Arteritis
Enrollment Status: Completed
Publish Date: July 12, 2022
VCRC Longitudinal Protocol for Takayasu's Arteritis
VCRC Longitudinal Protocol for Takayasu's Arteritis
Enrollment Status: Completed
Publish Date: July 12, 2022
VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu's Arteritis):Development as Clinical Trial Outcome Measures
VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu's Arteritis):Development as Clinical Trial Outcome Measures
Enrollment Status: Completed
Publish Date: October 19, 2018
View 7 Less Clinical Trials

74 Total Publications

A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research.
A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research.
Journal: BMC medical research methodology
Published: March 25, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Carette's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile